NCT05577104

Brief Summary

The study objective was to compare the efficacy of NPWT versus alginates dressings on the wound bed preparation prior to STSG surgery, as well as investigating the underlying mechanisms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2022

Completed
Last Updated

October 13, 2022

Status Verified

October 1, 2022

Enrollment Period

7 months

First QC Date

October 10, 2022

Last Update Submit

October 10, 2022

Conditions

Keywords

diabetic foot ulcersnegative pressure wound therapywound blood perfusionneutrophil extracellular traps

Outcome Measures

Primary Outcomes (1)

  • the time to STSG surgery

    the duration from first surgical debridement to STSG surgery

    3 months post debridement

Secondary Outcomes (2)

  • the wound blood perfusion

    Before the radical surgical debridement (Day 0), After NPWT or conventional dressing change therapy for 6 days (Day 6).

  • the wound neutrophil extracellular traps (NETs) formation

    Before the radical surgical debridement (Day 0), After NPWT or conventional dressing change therapy for 6 days (Day 6).

Study Arms (2)

the NPWT group

EXPERIMENTAL

For patients in the NPWT group, the wound bed preparation was facilitated by VAC device.

Procedure: Negative pressure wound therapy (NPWT)

the control group

ACTIVE COMPARATOR

For patients in the control group, the wound bed preparation was facilitated by alginates dressing change method.

Procedure: conventional moist dressings

Interventions

For patients in the NPWT group, the wound bed preparation was facilitated by vacuum-assisted closure (VAC).

the NPWT group

For patients in the control group, the wound bed preparation was facilitated by conventional dressing change method (with alginates ).

the control group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with DFUs aged 20-80 years.
  • Wagner grade 2 to 3.
  • Chronic DFUs wounds (duration of disease ≥ 2 weeks).
  • Ankle brachial ratio (ABI) 0.5~0.9, wound area 8\~20 cm2.

You may not qualify if:

  • Patients who were unable to complete the follow-up were not included,
  • Pregnant or nursing mothers were not included.
  • Patients with foot ulcers other than diabetes, peripheral vascular disease, organ dysfunctions (heart failure, respiratory failure, liver dysfunction, renal impairment or intestinal failure), or autoimmune diseases (rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, Sjogren's syndrome, connective tissues disease or systemic vasculitis) were not included.
  • Patients who received growth factors or hyperbaric oxygen therapies for the DFUs wounds within one month were not included.
  • Patients who had medications (such as corticosteroids, immunosuppressive agents or chemotherapy) within six months were not included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing First Hospital

Nanjing, Jiangsu, 210029, China

RECRUITING

Related Publications (1)

  • Tettelbach W, Cazzell S, Sigal F, Caporusso JM, Agnew PS, Hanft J, Dove C. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers. Int Wound J. 2019 Feb;16(1):122-130. doi: 10.1111/iwj.13001. Epub 2018 Sep 24.

Related Links

MeSH Terms

Conditions

Diabetic Foot

Interventions

Negative-Pressure Wound Therapy

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Intervention Hierarchy (Ancestors)

DrainageTherapeuticsSurgical Procedures, OperativeWound Closure Techniques

Study Officials

  • Yin Wu, phD

    The First Affiliated Hospital with Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The patients with diabetic foot ulcers (DFUs)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
attending doctor of Department of Burn and Plastic Surgery,Nanjing First Hospital

Study Record Dates

First Submitted

October 10, 2022

First Posted

October 13, 2022

Study Start

May 1, 2022

Primary Completion

December 1, 2022

Study Completion

December 10, 2022

Last Updated

October 13, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

The Study Protocol, Statistical Analysis Plan (SAP), Informed Consent Form (ICF), Clinical Study Report (CSR) are to be shared with other researchers.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
The data will become available on December,2023. The data will become available for 1 year.
Access Criteria
everyone
More information

Locations